Ownership history in UBS Group AG · 6 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in PORTAGE BIOTECH INC (PRTG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 167 | -47 | -22.0% | 0.00% | $100 | — |
| 2025 Q3 | REDUCED | 214 | -55 | -20.4% | 0.00% | $1K | — |
| 2025 Q2 | REDUCED | 269 | -9,944 | -97.4% | 0.00% | $1K | — |
| 2025 Q1 | ADDED | 10,213 | +6,617 | +184.0% | 0.00% | $94K | — |
| 2024 Q4 | ADDED | 3,596 | +1,130 | +45.8% | 0.00% | $19K | — |
| 2024 Q3 | INITIATED | 2,466 | — | — | 0.00% | $16K | — |
As of 2025 Q4 — sorted by position size